{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:01:12Z","timestamp":1774119672138,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,21]]},"DOI":"10.7759\/cureus.105611","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:07:48Z","timestamp":1774116468000},"source":"Crossref","is-referenced-by-count":0,"title":["Naltrexone as an Antipruritic Agent for Surgical Scar Pruritus"],"prefix":"10.7759","author":[{"given":"Manuela","family":"Florez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Nirmalani-Gandhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.03.046","article-title":"Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems","volume":"183","author":"Goonoo N","year":"2014","unstructured":"Goonoo N, Bhaw-Luximon A, Ujoodha R, Jhugroo A, Hulse GK, Jhurry D. Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems. J Control Release. 2014, 183:154-66. 10.1016\/j.jconrel.2014.03.046","journal-title":"J Control Release"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6040082","article-title":"Low-dose naltrexone (LDN)-review of therapeutic utilization","volume":"6","author":"Toljan K","year":"2018","unstructured":"Toljan K, Vrooman B. Low-dose naltrexone (LDN)-review of therapeutic utilization. Med Sci (Basel). 2018, 6:2. 10.3390\/medsci6040082","journal-title":"Med Sci (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.766","article-title":"An evidence-based review of systemic treatments for itch","volume":"20","author":"Pongcharoen P","year":"2016","unstructured":"Pongcharoen P, Fleischer AB Jr. An evidence-based review of systemic treatments for itch. Eur J Pain. 2016, 20:24-31. 10.1002\/ejp.766","journal-title":"Eur J Pain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.2.159","article-title":"Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus","volume":"28","author":"Lee J","year":"2016","unstructured":"Lee J, Shin JU, Noh S, Park CO, Lee KH. Clinical efficacy and safety of naltrexone combination therapy in older patients with severe pruritus. Ann Dermatol. 2016, 28:159-63. 10.5021\/ad.2016.28.2.159","journal-title":"Ann Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00797","article-title":"Naloxone and maintenance naltrexone as novel and effective therapies for immunotherapy-induced pruritus: a case report and brief literature review","volume":"15","author":"Singh R","year":"2019","unstructured":"Singh R, Patel P, Thakker M, Sharma P, Barnes M, Montana S. Naloxone and maintenance naltrexone as novel and effective therapies for immunotherapy-induced pruritus: a case report and brief literature review. J Oncol Pract. 2019, 15:347-8. 10.1200\/JOP.18.00797","journal-title":"J Oncol Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2011.12.003","article-title":"Post burn pruritus\u2014a review of current treatment options","volume":"38","author":"Zachariah JR","year":"2012","unstructured":"Zachariah JR, Rao AL, Prabha R, Gupta AK, Paul MK, Lamba S. Post burn pruritus\u2014a review of current treatment options. Burns. 2012, 38:621-9. 10.1016\/j.burns.2011.12.003","journal-title":"Burns"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5455\/PCP.20200401103430","article-title":"Oral naltrexone in the treatment of chronic psychogenic pruritus: a case report","volume":"30","author":"Aytulun A","year":"2020","unstructured":"Aytulun A, Ozcelik Eroglu E, Yildiz MI, Yalici Armagan B, Yazici MK. Oral naltrexone in the treatment of chronic psychogenic pruritus: a case report. Psychiatry Clin Psychopharmacol. 2020, 30:199-201. 10.5455\/PCP.20200401103430","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.08.052","article-title":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: a review","volume":"63","author":"Phan NQ","year":"2010","unstructured":"Phan NQ, Bernhard JD, Luger TA, St\u00e4nder S. Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010, 63:680-8. 10.1016\/j.jaad.2009.08.052","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler HR","year":"2018","unstructured":"Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018, 320:815-24. 10.1001\/jama.2018.11406","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1381983","article-title":"Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal","volume":"47","author":"Besirli A","year":"2014","unstructured":"Besirli A, E\u015fel E, \u00d6zsoy S, Turan T. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal. Pharmacopsychiatry. 2014, 47:151-5. 10.1055\/s-0034-1381983","journal-title":"Pharmacopsychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.17l02109","article-title":"Compulsive sexual behaviors treated with naltrexone monotherapy","volume":"20","author":"Camacho M","year":"2018","unstructured":"Camacho M, Moura AR, Oliveira-Maia AJ. Compulsive sexual behaviors treated with naltrexone monotherapy. Prim Care Companion CNS Disord. 2018, 20:9. 10.4088\/PCC.17l02109","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1389450120666190318121122","article-title":"The use of naltrexone in dermatology. Current evidence and future directions","volume":"20","author":"Sikora M","year":"2019","unstructured":"Sikora M, Rakowska A, Olszewska M, Rudnicka L. The use of naltrexone in dermatology. Current evidence and future directions. Curr Drug Targets. 2019, 20:1058-67. 10.2174\/1389450120666190318121122","journal-title":"Curr Drug Targets"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.031","article-title":"The uses of naltrexone in dermatologic conditions","volume":"80","author":"Lee B","year":"2019","unstructured":"Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019, 80:1746-52. 10.1016\/j.jaad.2018.12.031","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/356302-naltrexone-as-an-antipruritic-agent-for-surgical-scar-pruritus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:07:49Z","timestamp":1774116469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/356302-naltrexone-as-an-antipruritic-agent-for-surgical-scar-pruritus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.105611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,21]]}}}